Champions Oncology (CSBR) EPS (Basic) Growth (1y) (2012 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) EPS (Basic) Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | -6.64% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 36.50% |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -101.49% |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | -25.56% |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 96.64% |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 31.56% |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 64.10% |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 86.44% |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 64.10% |
| Jan 31, 2026 | -106.12% |
| Oct 31, 2025 | -67.91% |
| Jul 31, 2025 | -134.99% |
| Apr 30, 2025 | -1,569.66% |
| Jan 31, 2025 | 276.28% |
| Oct 31, 2024 | 134.90% |
| Jul 31, 2024 | 150.84% |
| Apr 30, 2024 | 95.75% |
| Jan 31, 2024 | -3.46% |
| Oct 31, 2023 | -12,874.04% |
| Jul 31, 2023 | -705.32% |
| Apr 30, 2023 | -625.54% |
| Jan 31, 2023 | -408.58% |
| Oct 31, 2022 | -105.73% |
| Jul 31, 2022 | -83.81% |
| Apr 30, 2022 | 49.11% |
| Jan 31, 2022 | -18.72% |
| Oct 31, 2021 | 26,848.50% |
| Jul 31, 2021 | -317.79% |